CTRI/2023/02/050073尚未招募未知
A Clinical Evaluation of Effectiveness Parameters with Gait Analysis Using MSO: A Comparative Pilot Study of MSO & the conventional Drop-Lock Calliper
Aneesh Karma0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adults both male and female above 18 years and below 50 years of age.
- •Should have a locomotory disorder with plus two power in lower limb as per Manual Muscle test (MMT)
- •Should be ambulatory with assistance or gait aids.
- •Self-consent to be the part of the Study
- •Should be able to speak, read and understand at least one of the following languages - Hindi, Marathi or English
- •Living in Mumbai/ Navi Mumbai till the course of study is completed
排除标准
- •Individuals less than 18 years and more than 50 years of age
- •Individuals with locomotory disorder with less than 2 muscle power.
研究者
相似试验
进行中（未招募）
不适用
Effectiveness of the bleaching technique delivered in custom-made or prefilled disposable traysSigns and symptoms in clinical findings, as darkened teethK00.8RBR-6gtj9kFapesp - Fundação de Amparo à Pesquisa do Estado de São Paulo
尚未招募
不适用
The Effect of Yashtyadi Kwath and Shunthyadi Pindi in the Management of Praklinna Vartma with special reference to Squamous BlepharitisCTRI/2022/07/044243Dr Akash Pralhad Gaikwad
已完成
不适用
Effectiveness of early nutrition in infants with esophageal atresiaEsophageal atresia.????? ??? ?? ?????? ?????IRCT2015110524893N1Mashhad University of Medical Sciences36
尚未招募
不适用
Efficacy and safety of Artesunate plus Sulfadoxine /Pyrimethamine and Artemether-Lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kassala (Kassala State), Kosti (White Nile State), Sinnar (Sinnar State), Damazin (Blue Nile State), and Gadaref (Gadaraf State), SudaACTRN12613000945729Republic of Sudan Federal Ministry of Health704
尚未招募
Unknown
A study to assess the clinical effectiveness and safety of intravesical mitomycin-C and gemcitabine sequential therapy in patients with high risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) Therapy: Prospective, multicenter, open-label trialKCT0009491ational Cancer Center82